Table 1 Descriptive characteristics of the patients with SARS-CoV-2 and control group.

From: Impaired pulmonary and muscle function during moderate exercise in female patients recovered from SARS-CoV-2

 

CG

SARS-CoV-2

p-value

Age (years)

45.7 (7.1)

46.4 (12.6)

0.841

Weight (kg)

65.3 (13.5)

74.5 (15.5)

0.061

Height (m)

1.6 (0.1)

1.6 (0.1)

0.224

BMI (kg min−2)

24.9 (5.8)

29.4 (5.9)

0.008

Adjusted morbidity groups (%)

Basal risk

100%

29.4%

 

Low risk

0%

41.2%

 

Moderate risk

0%

17.6%

 

High risk

0%

11.8%

 

Very high risk

0%

0%

 

FVC (L)

3.6 (0.3)

3.2 (0.7)

0.088

FVC (%)

100.5 (11.1)

86.4 (13.5)

0.005

FEV1 (L)

2.9 (0.3)

2.7 (0.6)

0.079

FEV1 (%)

104.9 (12.2)

91.4 (15.7)

0.016

FEV1/FVC (%)

83 (5.7)

83.2 (7.5)

0.932

VO2peak (mL kg m−1)

24.2 (5.3)

16.7 (5.4)

0.001

Peak power (W)

127.9 (32.6)

95.2 (31.5)

0.008

Power at VT1 (W)

57.7 (18.2)

35.4 (18.6)

0.002

  1. Data are provided as mean and standard deviation (SD).
  2. BMI body mass index, CG control group, FEV1 forced expiratory volume in the first second, FVC forced vital capacity, SARS-CoV-2 severe acute respiratory syndrome coronavirus type 2, VO2peak peak oxygen uptake, VT1 first ventilatory threshold.
  3. Significant values are given in bold.
Back to article page